Treatment of advanced cancer of the prostate
- 1 January 1985
- journal article
- clinical trial
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 1 (1) , 38-55
- https://doi.org/10.1002/ssu.2980010106
Abstract
Advanced cancer of the prostate may be either locally advanced or distant. Staging methods available to define the extent of the disease are relatively imprecise; non-invasive methods rely on tumour markers and radioisotopes; invasive methods range from fine needle aspiration to lymph node dissection. Exact definitions of criteria of response to treatment are essential to evaluate different forms of treatment. Primary treatment of metastatic disease is based on hormone manipulation. Those who either never respond or relapse after primary treatment may show some response to further hormone therapy but usually require the combination of radiotherapy and analgesia to control their symptoms. The response rates to chemotherapy are disappointing.Keywords
This publication has 72 references indexed in Scilit:
- Stage D1 adenocarcinoma of prostateUrology, 1984
- The Role of Routine Followup Bone Scans After Definitive Therapy of Localized Prostatic CancerJournal of Urology, 1982
- Prognosis of Patients With Stage D1 Prostatic AdenocarcinomaJournal of Urology, 1981
- Lymphograms in prostatic carcinoma: false-positive and false-negative assessments in radiologyThe British Journal of Radiology, 1981
- Morbidity of pelvic lymphadenectomyUrology, 1979
- Prostatic Carcinoma: Incidence and Location of Unsuspected Lymphatic MetastasesJournal of Urology, 1976
- Carcinoma of the Prostate: Biopsy and Conservative TherapyJournal of Urology, 1972
- Experiences with various operative procedures for the total excision of prostatic cancerCancer, 1959
- Present Status of Radioactive Gold Therapy in Management of Prostatic CancerJournal of Urology, 1959
- Hormone therapy in prostatic cancerThe American Journal of Medicine, 1956